Picture of GSK logo

GSK — GSK Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Momentum

Relative Strength (%)
1m+11.62%
3m+15.26%
6m+20.62%
1yr+28.14%
Volume Change (%)
10d/3m-9.96%
Price vs... (%)
52w High-34.51%
50d MA+2.2%
200d MA+11.03%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)14.12
PEG Ratio (f)0.81
EPS Growth (f)20.98%
Dividend Yield (f)3%
Valuation (ttm)IndustryMarket
Price to Book Value5.61
Price to Tang. Bookn/a
Price to Free Cashflow13
Price to Sales2.49
EV to EBITDA11.67

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.12%
Return on Equity32.94%
Operating Margin19.94%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue£m30,18630,82133,75434,09934,11436,600.7337,320.954.11%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+189.08-9.76+58.64-28.18-10.35+38.8+8.31n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for GSK

GSK (LON:GSK) price about to hit new 52-week high background image

GSK (LON:GSK) price about to hit new 52-week high

The good news for any holders of GSK (LON:GSK) is that the price is currently trading close to a 52 week high, with the share price up by around 2.45% to 1,737p over the past week.  For investors holding the stock (or considering buyin...

GlaxoSmithKline share price hits a new 52 week high background image

GlaxoSmithKline share price hits a new 52 week high

Shares in GlaxoSmithKline (LON:GSK) are currently trading close to a 52 week high, with the share price up by around 0.49% to 1,764p over the past week. On a one-month basis, the GlaxoSmithKline price has risen by 1.33%. For investors...

Glaxosmithkline share price hits a new 52 week high background image

Glaxosmithkline share price hits a new 52 week high

Shares in Glaxosmithkline (LON:GSK) are currently trading close to a 52 week high, with the share price up by around -1.65% to 1,781p over the past week. On a one-month basis, the Glaxosmithkline price has risen by 4.51%. For investors...

Can Glaxosmithkline ride out the impact of economic shocks? background image

Can Glaxosmithkline ride out the impact of economic shocks?

Geopolitical shockwaves and economic uncertainty are causing turmoil this year. Some shares are better able to absorb this kind of disruption than others - but could Glaxosmithkline (LON:GSK) be one of them?   To understand why differe...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of GSK EPS forecast chart

Profile Summary

GSK plc, formerly GlaxoSmithKline PLC is a global healthcare company. The Company is focused to improve the quality of human life by helping people. The Company operates through three core businesses: Pharmaceuticals, Vaccines and Consumer Healthcare. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency viruses (HIV), immuno-inflammation and oncology. It also focuses on immunology, human genetics, and advanced technologies to deliver transformational new medicines for patients. The Company's research and development focuses on developing vaccines against infectious diseases that combine high medical needs and market potential. The Company's Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, minerals and supplements. It provides prescription medicines, vaccines, and consumer healthcare products.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
December 6th, 1999
Public Since
May 22nd, 1972
No. of Shareholders
97,570
No. of Employees
90,096
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
5,084,151,821

GSK Share Price Performance

Latest News for GSK

Upcoming Events for GSK

GSK plc Ordinary Shareholders Meeting

Q2 2022 GlaxoSmithKline PLC Earnings Release

Dividend For GSK.BA - 0.1225 USD

Q3 2022 GlaxoSmithKline PLC Earnings Release

Similar to GSK

Picture of Abcam logo

Abcam

gb flag iconLondon Stock Exchange

Picture of Alliance Pharma logo

Alliance Pharma

gb flag iconLondon Stock Exchange

Picture of Animalcare logo

Animalcare

gb flag iconLondon Stock Exchange

Picture of AstraZeneca logo

AstraZeneca

gb flag iconLondon Stock Exchange

Picture of Benchmark Holdings logo

Benchmark Holdings

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email